← Back to catalogue

Atellica CH Diazo Direct Bilirubin (D_DBil)

FDA UDI

Class II (US FDA UDI)

by Siemens Healthcare Diagnostics

Identity

Trade Name
Atellica CH Diazo Direct Bilirubin (D_DBil) FDA UDI
Generic Name
Conjugated (direct) bilirubin IVD, kit, spectrophotometry FDA UDI
Device Name
Atellica CH Diazo Direct Bilirubin (D_TBil) FDA UDI
Model / Reference
11537219 FDA UDI
Description
Atellica CH Diazo Direct Bilirubin (D_TBil) FDA UDI

Identifiers

Catalog Number
11537219 FDA UDI
Primary DI / UDI-DI
00630414614755 FDA UDI
510(k) Number
K223078 FDA UDI
FDA Product Code
CIG FDA UDI
GMDN Term
Conjugated (direct) bilirubin IVD, kit, spectrophotometry FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1110 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Conjugated (direct) bilirubin IVD, kit, spectrophotometry

Atellica CH Diazo Direct Bilirubin (D_DBil) by Siemens Healthcare Diagnostics — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Conjugated (direct) bilirubin IVD, kit, spectrophotometry.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI fe2e3cd7-031b-45dd-b084-8487e10acf57 37 fields · synced May 30, 2026